Abstract:This study investigates the feasibility of fabrication of poly(1-vinyl-2-pyrrolidone) (Kollidon®25)-mediated filaments for producing tinidazole (TNZ)-loaded, customizable, child-friendly tablets (with varying shapes and sizes) using hot melt extrusion (HME) coupled with fused deposition modeling (FDM) technology. Kollidon®25, chosen for its ability to enhance the dissolution of TNZ (a BCS Class II drug), was evaluated for polymer-drug compatibility through Hansen solubility, polarity, and interaction parameter analyses, confirming good miscibility and affinity between TNZ and Kollidon®25. Placebo- and TNZ-loaded filaments were prepared in different ratios using HME, followed by the development of 3D-printed tablets via FDM. The fabricated batches of placebo and TNZ-loaded 3D tablets were characterized, and it was found that they had an average weight variation of 270.41 ± 7.44 mg and 270.87 ± 9.33 mg, hardness of 155.01 ± 11.79 N and 265.3 ± 7.62 N, and friability of 0.1583 ± 0.0011 % and 0.2254 ± 0.0013 %. Amorphization was confirmed by differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD) analysis. Scanning electron microscopy (SEM) revealed a layer-by-layer pattern with tiny fractures on the tablet surfaces, which enhanced media penetration, resulting in improved dissolution profiles. The TNZ release profile showed complete 100 % release within 2.0 h in a gastric acidic medium. These findings support the potential of Kollidon®25 to create customizable, child-friendly, 3D-printed dosage forms with different shapes and sizes for TNZ delivery, offering a unique approach to paediatric medications.

[Preparation of Biodegradable and Sustained Release Gel of Tinidazole].

Formulation of in Situ Forming Sustained Release Gel of Tinidazole

Preparation and Stability Study on Tinidazole in Situ Forming Sustained-Release Injection

Preparation and in vitro release of poly(DL-lactide) microspheres containing tinidazole

[Preparation and in Vitro and in Vivo Study on Tinidazole in Situ Forming Sustained-Release Injection].

Preparation and Structure Characterization of Poly(Lactide-Co-Ethylene Carbonate) Microspheres

Preparation and Quality Control of Tinidazole T-sensitive In-situ Gel for Vaginal Application

Formulation and evaluation of in situ forming PLA implant containing tinidazole for the treatment of periodontitis.

Dynamic release of tinidazole from the degradable PLLA-tinidazole blend gel]

Study on the Preparation of Tinidazole Compound Gel and its Quality Controlled

Synthesis, Characterization and Evaluation of Tinidazole-Loaded Mpeg-Pdlla (10/90) in Situ Gel Forming System for Periodontitis Treatment

The Preparation and the Determination of Content and Entrapment Efficiency by HPLC of the Sustained Release Microspheres of Tinidazole

3D printed tinidazole tablets coupled with melt-extrusion techniques for formulating child friendly medicines

Study of an Injectable in Situ Forming Gel for Sustained-Release of Ivermectin in Vitro and in Vivo.

Preparation of Nimodipine Gelatin Microspheres and Study of Its Characteristics

Preparation of Tolterodine Metabolite Loaded Biodegradable Plga Microspheres

Preformulation study on thermosensitive injectable hydrogel of N'-dodecanoylisoniazid

Design and in Vitro Evaluation of a Novel Poly(methacrylic Acid)/metronidazole Antibacterial Nanogel As an Oral Dosage Form.

Formulation of Porous Poly(lactic-Co-glycolic Acid) Microparticles by Electrospray Deposition Method for Controlled Drug Release

Preparation of thermo-sensitive diammonium glycyrrhizinate binary liposome gel and the in vitro drug-release behaviors

Preparation, Characterization and in Vitro Evaluation of IVM Loaded Poly(lactic-Co-Glycolic Acid) (PLGA) Microspheres